knowledge -WSS

knowledge

author：Wikipedia 2025-09-30 16:59:35 - browse：977

Photo illustration of Chris Viehbacher -- biotech coverage from STAT — Chris Viehbacher took over as Biogen CEO in November. Suzanne Kreiter/Globe staff; Photo illustration Alex Hogan/STAT

This was supposed to be the new Biogen. When Chris Viehbacher, a respected pharmaceutical executive, took over as CEO in November, Wall Street saw him as a steadying force for the wayward company and a strong personality who would stand up to its quarrelsome board.

Instead, Biogen’s board has saddled Viehbacher with the first crisis of his tenure at the company. Alex Denner, a long-time director, nominated a biotech executive who is also the mother of his child to succeed him on the board, and Biogen chose not to disclose the couple’s relationship to shareholders, an omission that shocked people close to the company and undermined the notion that Biogen was changing for the better.

“It’s just disappointing to see after all the criticism that has been levied at the company over the last few years, there really seems to be no self-awareness going into this recommendation,” said Brian Skorney, a securities analyst at Baird who covers Biogen.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Stopping antidepressants leads to symptoms for 1 in 6 patients

Wikipedia

WSS

Beware the threat of staffing cuts at the CDC

Liz Cheney makes 1st public comment since Trump's election interference indictments

Eli Lilly’s Zepbound improved liver scarring in mid

Hilary may become 1st tropical storm to make landfall in California in 84 years

Evacuations in place as 3 wildfires burn in eastern Washington state

FDA approves first treatment for ultra

hotspot

knowledge

Wikipedia

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Clinical trials must include more disabled people

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Eli Lilly’s Zepbound improved liver scarring in mid

Duchenne breakthrough therapy leaves behind pioneering families

New details revealed about Purdue's marketing of OxyContin

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Fight over Supreme Court dialysis ruling puts kidney patients at risk

Medicare details structure of new drug price negotiation program

Cancer drug shortages' outsize impact on ovarian cancer patients

focus

An interview with Robert F. Kennedy Jr. on vaccines

'Little Tech' descents on D.C., wanting a say in how AI is regulated

UnitedHealth CEO's Medicaid comments send insurer stocks diving

Trump's false claims about Georgia's 2020 election long debunked

CMS got Medicare Advantage quality rating wrong, judge rules

Structure Therapeutics oral GLP

entertainment

Wikipedia

Wikipedia

knowledge